Somebody call the wahmbulance. Your chart said because it was...

First 27 Last

Share
Profile

Follow
colesyoz

250 Posts.

40

16/10/17

15:22

Post #: 27936915
Share

Originally posted by robbo24 ↑

That's great guys - you don't believe in the power of NUGGET HYPE and that's perfectly fine.

However, if as you say you are holders of the stock and you have bullish analysis (or even bearish analysis, which would be ironic) then by all means post it up.

If you disagree with the idea of NUGGET HYPE then that's great - perhaps try your hand explaining it over at ARV where NUGGET HYPE has achieved a higher MCAP than MOY.

You can brush it off with analogies about blank canvas all you like - the practical reality is that MOY is undervalued at a current, fundamental level and on a technical level relative to past shareprice levels and taking into account "nearology".

I note that colesyoz presented an inaccurate description of the MOY chart and I posted a perfectly polite and "matter of fact" description of where his post fell short of accuracy. I have to suggest though, colesyoz, that name calling and using rude words is not a helpful way to have a discussion. I won't engage for long with activities like that.

Expand

Somebody call the wahmbulance. Your chart said because it was once x it must go past x again. Where's new beginning these days? He spent every day for about 6 months telling everyone about his charts that said sp was in the 3rd wave. That was at .3. Some of us don't need catchphrases to explain and determine the potential of this company.

MOY Price at posting: 18.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

EBR

EBR reaches review milestone for wireless cardiac pacing device

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Results wrap: Austal, TPG Telecom and Downer

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

HLX

Helix investor makes partial takeover bid, proposing board changes

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud